-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Upgrades Intellia Therapeutics to Buy, Announces $29 Price Target

Benzinga·03/04/2026 12:20:01
Listen to the news
Jones Trading analyst Debanjana Chatterjee upgrades Intellia Therapeutics (NASDAQ:NTLA) from Hold to Buy and announces $29 price target.